ÂÜÀòÂÒÂ×

Marion Pillwein is a seasoned professional in Quality Risk Management with extensive experience in the pharmaceutical industry, currently serving as Director of R&D Quality Risk Management at Bristol Myers Squibb since February 2022. Prior to this role, Marion Pillwein worked at Merck Serono as the R&D Quality Risk Management Lead and held positions as Associate Director Quality Management, focusing on corrective and preventive actions and root cause analysis. Marion Pillwein has also provided GCP auditing and consulting services independently and at Imclone Systems International, Nycomed, and Altana Pharma, showcasing expertise in risk-based strategic audit planning, development of quality management systems, and comprehensive training in GCP. Educational qualifications include a PhD in Microbiology from the University of Veterinary Medicine Vienna and a Diploma in Microbiology and Biochemistry from the University of Vienna.